(NASDAQ: TWST) Twist Bioscience's forecast annual revenue growth rate of 23.13% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.02%, and it is also forecast to beat the US market's average forecast revenue growth rate of 8.82%.
Twist Bioscience's revenue in 2024 is $295,210,000.On average, 4 Wall Street analysts forecast TWST's revenue for 2025 to be $22,123,054,457, with the lowest TWST revenue forecast at $21,559,633,280, and the highest TWST revenue forecast at $23,000,847,896.
In 2026, TWST is forecast to generate $26,221,025,187 in revenue, with the lowest revenue forecast at $25,834,650,781 and the highest revenue forecast at $26,607,399,594.